Fulgent Genetics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 71.1M | 83.3M | 84.1M | 81.8M | 73.5M | 76.2M | 71.7M | 71.0M |
| Cost of Goods Sold | 49.6M | 50.8M | 48.6M | 47.4M | 45.1M | 44.4M | 45.0M | 44.5M |
| Gross Profit | 21.5M | 32.6M | 35.5M | 34.4M | 28.3M | 31.8M | 26.8M | 26.5M |
| R&D Expenses | 14.2M | 14.2M | 13.9M | 13.5M | 12.4M | 12.1M | 11.8M | 13.5M |
| Operating Expenses | 56.1M | 68.8M | 50.9M | 54.1M | 48.1M | 48.0M | 43.9M | 45.4M |
| Operating Income | -34.6M | -36.2M | -15.3M | -19.7M | -19.8M | -16.1M | -17.1M | -18.9M |
| Other Income / Gains | 8.6M | 7.0M | 9.2M | -1.8M | 8.1M | 8.1M | -1.5M | 7.7M |
| Net Income | -24.8M | -23.4M | -6.6M | -19.0M | -11.5M | -5.9M | -14.6M | -8.7M |
| EPS (Diluted) | -0.80 | -0.76 | -0.21 | -0.61 | -0.37 | -0.19 | -0.48 | -0.29 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.302 | 0.391 | 0.422 | 0.421 | 0.386 | 0.418 | 0.373 | 0.373 |
| General And Administrative Expenses | 27.7M | 41.6M | 23.3M | 26.4M | 25.3M | 24.3M | 20.9M | 21.3M |
| Selling And Marketing Expenses | 12.2M | 11.0M | 11.6M | 12.3M | 8.5M | 9.5M | 9.1M | 8.6M |
| Selling General And Administrative Expenses | 39.9M | 52.6M | 35.0M | 38.7M | 33.8M | 33.9M | 30.1M | 29.9M |
| Other Expenses | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M |
| Cost And Expenses | 105.8M | 119.6M | 99.4M | 101.5M | 93.3M | 92.3M | 88.8M | 89.9M |
| Interest Income | 8.7M | 6.9M | 7.9M | 8.1M | 8.0M | 8.3M | 8.1M | 7.7M |
| Interest Expense | 17K | 134K | 28K | 17K | 14K | 210K | 14K | 0 |
| Depreciation And Amortization | 6.0M | 6.1M | 6.0M | 6.1M | 5.9M | 6.2M | 5.9M | 6.2M |
| Ebitda | -20.0M | -23.0M | -77K | -15.4M | -5.8M | -9.9M | -12.6M | -5.0M |
| Ebitdaratio | -0.281 | -0.276 | -0.001 | -0.189 | -0.079 | -0.13 | -0.176 | -0.071 |
| Operating Income Ratio | -0.487 | -0.435 | -0.183 | -0.241 | -0.269 | -0.212 | -0.238 | -0.266 |
| Income Before Tax | -26.0M | -29.3M | -6.1M | -21.5M | -11.7M | -8.0M | -18.5M | -11.2M |
| Income Before Tax Ratio | -0.365 | -0.351 | -0.073 | -0.263 | -0.16 | -0.106 | -0.258 | -0.158 |
| Income Tax Expense | -704K | -5.6M | 683K | -2.3M | 176K | -1.9M | -3.8M | -2.1M |
| Net Income Ratio | -0.349 | -0.281 | -0.079 | -0.232 | -0.157 | -0.077 | -0.204 | -0.123 |
| Epsdiluted | -0.80 | -0.76 | -0.21 | -0.61 | -0.37 | -0.19 | -0.48 | -0.29 |
| Weighted Average Shs Out | 30.9M | 30.8M | 30.7M | 30.8M | 30.8M | 30.7M | 30.4M | 30.1M |
| Weighted Average Shs Out Dil | 30.9M | 30.8M | 30.7M | 30.8M | 30.8M | 30.7M | 30.4M | 30.1M |